FDA aiming to give final approval to Pfizer vaccine by early next month

Reuters|
PrintFind an error? Report us
The U.S. Food and Drug Administration is aiming to give full approval for the Pfizer COVID vaccine by early September, the New York Times reported on Tuesday, citing people involved in the effort.
The FDA gave emergency use authorization to the Pfizer vaccine late last year. Full approval by the FDA could push more Americans to get the COVID-19 vaccine as it might reduce their fears about the safety of the shot.
The agency's unofficial deadline for the approval is the Sept. 6 Labor Day holiday, the Times said.
U.S. President Joe Biden said last week he expected the FDA to make the decision by early fall.
Comments
The commenter agrees to the privacy policy of Ynet News and agrees not to submit comments that violate the terms of use, including incitement, libel and expressions that exceed the accepted norms of freedom of speech.
""